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Background: The objectives of study were to investigate the effects of cinnamon supplementation on
antioxidant status and serum lipids in women with polycystic ovary syndrome (PCOS).
Methods: This double-blind randomized controlled clinical trial was conducted on 84 overweight or
obese PCOS patients; aged 20e38 years. Subjects in cinnamon (n ¼ 42) and placebo (n ¼ 42) groups were
given 3 cinnamon capsules (each one contained 500 mg cinnamon) or placebo daily for 8 weeks. Fasting
blood samples, anthropometric measurements and dietary intake data were gathered at the beginning
and at the end of the study. Independent t test, paired t test and analysis of covariance were used to
analyze of data.
Results: Cinnamon signiﬁcantly increased serum total antioxidant capacity (P ¼ 0.005). Malondialdehyde
was signiﬁcantly decreased compared with placebo (P ¼ 0.014). Cinnamon supplementation signiﬁcantly
improved serum level of total cholesterol, low-density lipoprotein cholesterol and high-density lipo-
protein cholesterol (all P < 0.05). No signiﬁcant effect was detected on serum triglyceride level.
Conclusions: Cinnamon supplementation improved antioxidant status and serum lipid proﬁle in women
with PCOS and may be applicable for reducing PCOS risk factors.
© 2018 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Polycystic ovary syndrome (PCOS) is a common metabolic and
reproductive condition in women with an estimated prevalence of
6% to as high as 26%.1,2 This disorder is accompanied with irregular
menstrual cycle, chronic anovulation and hyperandrogenism. PCOS
is associated with complications in different health aspects,
including obesity, insulin resistance, infertility, diabetes and, Department of Nutrition in
Tabriz University of Medical
00@yahoo.com (M. Rafraf).
for Food and Biomolecules,
National Taiwan University. Produc
es/by-nc-nd/4.0/).atherosclerosis.3 Oxidative stress (OS) as one of the main causes of
molecular damage to cellular is increased inwomenwith the PCOS.
Obesity and insulin resistance play a vital role in the pathogenesis
of PCOS and subsequently increased OS in these patients. In
addition, the resultant oxidative stress induces an inﬂammatory
environment furthering elevated insulin resistance and contrib-
uting to hyperandrogenism,4 dyslipidemia, hypertension and etc.5,6
Numerous investigations have revealed that oxidative stress level is
signiﬁcantly increased in patients with PCOS compared with the
normal ones. Fenkci et al revealed that patients with PCOS had
higher OS and increased OS is related to hyperandrogenism status.7
In another study, Desai et al displayed that the OS is also present in
non-obese women with PCOS.8
PCOS is a condition with a signiﬁcant decrease in serum anti-
oxidant. Therefore, antioxidant supplementation may be effective in
these patients. Antioxidants are considered signiﬁcant agents in thetion and hosting by Elsevier Taiwan LLC. This is an open access article under the CC
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dants, as well as herbal agents, might help to reduce OS.9 Further-
more, medicinal herbs are expected to have a similar degree of
efﬁcacy without the side effects related to conventional medication.
Cinnamomum zeylanicum, is an herbaceous plant, belonging to
the Lauraceae family. It is one of the most important spices used by
people all over the world. Different ﬂavonoids and Polyphenols
isolated from cinnamon have free-radical-scavenging activities and
antioxidant properties.10 These compounds have been revealed to
decrease oxidative stress in a dose-dependent manner through the
inhibition of 5-lipoxygenase.11 Antihyperlipidemic and antioxidant
activity of cinnamon has been proven in experimental studies.12e17
In animal study, Shalaby et al indicated that consumption of cin-
namon aqueous extract improved activity of tissue antioxidant
enzymes in obese diabetic rat.18 Additionally, in the study by Kim
et al, cinnamon lowered total cholesterol and triglyceride levels in
diabetic mice.19 Roussel et al showed that supplementation of
250 mg/day of an aqueous extract of cinnamon increased the
plasma levels of thiol group and decreased malondialdehyde
compared to those of placebo in patients with impaired fasting
blood glucose for 12 weeks.20
Although some studies have reported the effects of cinnamon on
oxidative stress and lipids proﬁle in several diseases,5,6,21 Its
possible effects on serum antioxidant status and lipids proﬁle of
women with PCOS have not been studied. Therefore, we initiated a
study to assess the effects of cinnamon supplementation on
oxidative stress including serum total antioxidant capacity (TAC),
malondialdehyde (MDA) and lipids in women with PCOS.
2. Material and methods
2.1. Design study
A total of 84 women with PCOS aged 20e38 years with a BMI
between 25e40 kg/m2 were enrolled in this double-blind, ran-
domized, controlled clinical trial from the Gynecology clinic,
Mohheb Yas Hospital in Tehran, Iran from October 2015 to February
2016. The sample size was determined based on the information
acquired from the study by Kort et al for IR.22 Considering 95%
conﬁdence interval and 80% power, the sample size was computed
to be 32 per group. This number was increased to 42 per group to
accommodate the anticipated dropout rate.
The diagnosis of PCOS was established according to 2003 Rot-
terdam criteria, which require at least two of three features for
diagnosis: chronic amenorrhea or oligo-amenorrhea, clinical and/
or biochemical features of hyperandrogenism and polycystic
ovaries by ultrasonography.1 Study exclusion criteria included:
thyroid disorders, hyperprolactinemia, diabetes mellitus, preg-
nancy and lactation, liver or kidney diseases, Cushing syndrome,
cardiovascular diseases, seizure and cerebrovascular disorder, hy-
pertension, the use of medications such as insulin sensitizers, in-
sulin, B-blockers, cholesterol-lowering drugs and dietary
supplements, smoking, current treatment of infertility, inhaled
corticosteroid use, following a speciﬁc diet and regular exercise (>2
weeks) and allergy to cinnamon. The Ethical Committee of Tabriz
University of Medical Science approved the study protocol and was
registered on the Iranian Registry of Clinical Trials website (iden-
tiﬁer: IRCT201508173664N14). Written informed consent was
gained from each subject. The participants were randomly allo-
cated into two groups using a block randomization procedure with
matched subjects in each block based on age and BMI. Subjects
were questioned to continue their usual dietary intakes and
physical activity during the study.
A general questionnaire was completed for each patient. Body
weight was measured using a scale (Seca, Hamburg, Germany),without shoes and wearing light clothing. Height was measured
using a mounted tape without shoes. BMI was calculated as the
weight in kilogram divided by the height in meters squared. In-
formation about daily energy and macronutrient intakes were ob-
tained by 24-h recall method for 3 d, including 2 d during the week
and 1 during the weekend. A three day average for energy and
macronutrient intakes of all subjects was analyzed by Nutritionist 4
software (First Databank Inc., San Bruno, CA).
Cinnamon bark was provided from the Iranian Institute of me-
dicinal plants, Tehran, Iran. Cinnamon barks were grinded with a
plant tissue grinder. Each capsule containing approximately of
500 mg cinnamon powder was manufactured on October 2015.
Subjects in the treatment group received three capsules of cinna-
mon and control group subjects received three placebo capsules
(wheat ﬂour) that they were required to take daily for 8 weeks. The
compliance of the volunteers with the study protocol was moni-
tored via phone interviews once per week and also by counting
returned capsules every 2 weeks.
2.2. Blood sampling and biochemical assays
Blood samples (5 ml) were collected after a 12-h overnight
fasting, in the morning. The serum samples were separated from
whole blood by centrifugation at 2606.8 g for 10 min (Beckman
Avanti J-25; Beckman Coulter, Brea, CA, USA). The serum samples
were frozen immediately at 70 C until assay. Serum total
cholesterol (TC), triacylglycerol (TG) and high-density lipoprotein
cholesterol (HDL-C) were measured using the standard enzymatic
methods by Pars Azmun kit (Karaj, Iran). Low-density lipoprotein
cholesterol (LDL-C) concentration was determined by the Friede-
wald formula: LDL C¼ TC (HDL Cþ TG/5).23 Measurement of
TAC in serum was performed by using the colorimetric method
with commercial kits (TAC, RANDOX kits; UK).24e26 The serumMDA
level was estimated by using a reactionwith thiobarbituric acid as a
thiobarbituric acid reactive substance to produce a pink colored
complex. Next, its ﬂuorescence intensity was measured at 547 nm
with excitation at 525 nm by a spectroﬂuorimeter (model SFM 25
A; Kontron, Milan, Italy).27 All anthropometric, dietary intakes,
blood sampling and biochemical measurements were assessed
again at the end of intervention period in both groups.
2.3. Statistical analyses
The collected data were analyzed using the statistical software
SPSS, version 22. (SPSS Inc., Chicago, IL, USA) and the results are
expressed as means ± SD. The normality of the distribution of
variables was checked by KurtosiseSkewness test. The baseline
measurements and dietary intakes of subjects in two groups were
compared using independent samples t test and chi-square test for
quantitative and qualitative variables, respectively. Analysis of
covariance (ANCOVA) was used to identify any differences between
the two groups after intervention, adjusting for baseline mea-
surements and confounders (BMI and energy changes during
study). The changes in anthropometric measurements, energy and
nutrient intakes and blood parameters of the participants between
the beginning and end of the trial were compared by paired sam-
ples t test. The percentage of changes in variables after intervention
was determined with the formula: [(after values  before values)/
before values]  100. Results with P < 0.05 were considered as
statistically signiﬁcant.
3. Results
All of the patients (42 patients in cinnamon group and 42 pa-
tients in placebo group) completed the study (Fig. 1). Compliance
Recruitment and assessed for eligibility (n=100)
Not selected (n=16): Not meeting inclusion criteria (n=16)
Eligible (n=84)
Randomized (n=84)
Allocation
Allocated to experimental group (n=42)
Cinnamon 
One capsule of cinnamon 3 times a day 
for 8 weeks
Allocated to experimental group (n=42)
Control
One capsule of placebo 3 times a day 
for 8 weeks
Follow-up (n=42) Follow-up (n=42)
Analyzed (n=42) Analyzed (n=42)
Fig. 1. Participant's ﬂow diagram.
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consumed during the study period. No side effects were reported
from participants during study period.
General and biochemical characteristics of participants at the
beginning and end of the study are shown in Table 1. There were no
signiﬁcant differences between groups in BMI and daily energy
intake in the beginning of the study and after 8 weeks of inter-
vention. Signiﬁcant differences were seen between the two groups
in serum levels of MDA at baseline. Levels of TAC were not different
between two groups at baseline. Serum TAC levels signiﬁcantly
change in cinnamon group after intervention compared to their
baseline values (P ¼ 0.001). Variations in MDA levels were not
signiﬁcant (P ¼ 0.102) compare to baseline value. Serum levels of
TAC and MDA did not alter signiﬁcantly in control group. Results of
ANCOVA test showed statistically signiﬁcant differences between
two studied groups in serum TAC (P ¼ 0.005) and MDA (P ¼ 0.014)
at the end of the study, adjusted for BMI and energy intake. Serum
levels of TAC signiﬁcantly increased in the cinnamon group by 9.28
% at the end of the study. Signiﬁcant decrease in serum levels of
MDA by 7.87% was obtained in cinnamon group over the 8 week in
comparison to baseline values.
Fig. 2(AeD) illustrates changes in serum levels of TG, TC, LDL-C
and HDL-C of studied groups and during 8-wk period of study. No
signiﬁcant differences were seen in serum levels of lipids between
the two groups at baselines. As shown in Fig. 2(BeD), signiﬁcant
differences were seen between two studied groups in serum levelsof TC, LDL-C and HDL-C at the end of the study adjusted for energy,
BMI and baseline values (P < 0.05). Changes in serum TG (P ¼ 0.71)
was not signiﬁcant. (Fig. 2A). Serum levels of TG, TC and LDL-C
signiﬁcantly decreased in the intervention group by 18.24 % (vs.
5.42 % decrease in control group), 7.73 % (vs. 2.10 % decrease in
control group) and 10.24 % (vs. 0.63 % decrease in control group),
respectively, at the end of the study in comparison to baseline
values. (data not shown).
4. Discussion
Cinnamon has been used as a traditional herbal medicine for
centuries. This spice has been found to have strong antioxidant,
antihyperlipidemia5 and anti-inﬂammatory properties. To our
knowledge, only few studies revealed antioxidant effects of cin-
namon. Based on our literature review, this is the ﬁrst report con-
cerning the effects of cinnamon consumption on antioxidant status
and serum lipid levels in women with PCOS.
Based on results BMI and daily energy intake of subjects did not
change signiﬁcantly in any of groups throughout the study, there-
fore, these variables could not be accounted as confounding factors
in interpreting biochemical ﬁndings.
Exposure to endocrine and metabolic disturbances such as
hyperandrogenism, hyperinsulinemia and dyslipidemia might be
responsible for PCOS-associated oxidative stress.28 Reactive oxygen
species react with lipids causing peroxidative changes that result in
Table 1
General characteristics and antioxidant status of the women with PCOS at baseline and after 8-week of intervention.
variable Measurement period Cinnamon group (n ¼ 42) Control group (n ¼ 42) MD (95 % CI), p value
Age (y) Baseline 29.26 (6.14) 30.17 (6.69)
BMI (kg/m2) Baseline
After intervention
30.75 (5.04)
30.62 (4.99)
31.61 (4.84)
31.60 (4.87)
Energy (kcal/d) Baseline
After intervention
1651.2(251.09)
1602.4(265.73)
1749.3 (265.38)
1696 (264.71)
TAC (mmol/L) Baseline
After intervention
MD (95% CI), P-valueb
1.66 (0.32)
1.83 (0.42)
0.165 (0.07e0.25), 0.001
1.79 (0.39)
1.73 (0.32)
0.055 (0.18 to 0.07),0.38
0.126 (0.266 to 0.013), 0.076a
0.225 (0.06e0.38), 0.005c
MDA (nmol/mL) Baseline
After intervention
MD (95% CI), P-valueb
2.33 (0.63)
2.16 (0.75)
0.173 (0.38 to 0.03), 0.107
2.06 (0.56)
2.26 (0.73)
0.197 (0.02 to 0.41),0.07
0.269 (0.006e0.53),0.044a
0.385 (0.68 to 0.08), 0.014c
BMI body mass index, MDA malondialdehyde, TAC total antioxidant status, MD mean difference, CI conﬁdence interval.
The results are described as means ± Standard Deviation (SD).
a MD (95% CI), P-value is reported based on the analysis of independent sample t test.
b MD (95% CI), P-value is reported based on the analysis of paired sample t test.
c MD (95% CI), P-value is reported based on the analysis of covariance.
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Fig. 2. Effects of cinnamon on (A) triglyceride, (B) cholesterol levels, (C) low density lipoprotein and (D) High density lipoprotein. Data were present as means ± SE for 42 PCOS
patients in each group. $P < 0.05 for within group comparisons (paired sample t test); *P < 0.05 for between group comparisons (ANCOVA adjusted for baseline value, BMI and
energy intake daily).
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cator of the overall protective effect of antioxidants in body ﬂuids, on
cell membranes and other components of cells against oxidative
injury.30 According to our results, cinnamon supplementation
caused a signiﬁcant increase in TAC levels and decreasedMDA levels
compared with placebo group. Our ﬁndings also were similar with
results of other studies.31,32 Salih indicated that consumption of 1 g/
day of cinnamon improved oxidative stress markers among poorly
controlled type 2 diabetes patients for 12 weeks.32 In anexperimental study, Sari€ozkan demonstrated that cinnamon bark oil
had protective effect on oxidant/antioxidant balance, in 88 adult
diabeticmale rats for 10weeks.33 Various studies reported that ether,
aqueous and metabolic extracts of cinnamon have considerable
antioxidant activities.34,35 Faix et al revealed that considerably lower
lipid peroxidation in plasma and duodenal epithelium of chicks fed
the diet supplemented with 0.10% of cinnamon essential oil.36
It was revealed that cinnamon has high levels of different phy-
tochemicals compoundswith free radical scavenger actions, such as
A. Borzoei et al. / Journal of Traditional and Complementary Medicine 8 (2018) 128e133132epicatechin, camphene, eugenol, gamma-terpinene, phenol, sali-
cylic acid and tannins.37 Proanthocyanidins, which are high in
cinnamon, are plant metabolites with antioxidant activity.38 Hence,
cinnamon is rich in antioxidants. These components inhibit
peroxynitrite-induced nitration and fatty acid as well as lipid per-
oxidation in the b-carotene-linoleic acid system in vitro models.35
They display a protective capacity against irradiation induced
lipid peroxidation in liposomes and quench hydroxyl radicals and
hydrogen peroxide.39 The ethanolic extract of cinnamon has been
demonstrated to decrease the carbon tetrachloride induced lipid
peroxidation and as a result, a fall occurs in themarkers of oxidative
stress such as MDA.40
Our results demonstrated that cinnamon supplementation had
antioxidant capability and improved the oxidative stress in the
studied subjects. It was possible that the elevate in TAC in our
cinnamon treated group might be due to their decreased con-
sumption for free radical detoxiﬁcation or utilization which was
approved by following reduction in serum MDA and improvement
in TAC levels.
Our ﬁndings indicated that supplementation of cinnamon
signiﬁcantly decreased serum levels of TC and LDL-C and increased
HDL-C levels. These results are in agreement with ﬁndings of some
others studies.41e43 Soliman showed that supplementation with
1.5 g/day and 3 g/day of cinnamon for 45 days, signiﬁcantly
decreased TG, TC and LDL-C levels in patients with type 2 dia-
betes.44 Khadem et al showed that 1.5 g/day of cinnamon for 8
weeks, improved lipid proﬁles in type 2 diabetic patients.45 In an-
imal study, Sambaiah demonstrated that cinnamon reduced serum
TC level in rats even after increasing the intake up to 5 times the
normal intake.46 Quin et al showed that cinnamon administration
(50 mg/kg daily) for 8 weeks decreased TG, TC, chylomicron-
apoB48 and VLDL-apoB100 in Wistar rats fed on a high-fructose
diet to induce insulin resistance.47 Recent study suggested that
cinnamon extract may improve insulin action via increasing
glucose uptake, perhaps through enhancing the insulin-signaling
pathway in skeletal muscle.38
It was proposed that antihyperlipidemic activity of cinnamon
might be due to its high contents of polyphenols inhibiting the
intestinal absorption of cholesterol with subsequent hypo-
cholesterolemic activity.18 In another study, cinnamaldehyde
changed serum biochemical factors associated with lipolysis, such
as glycerol and free fatty acid levels and increased adipose tissue
lipolysis in high-fat diet-fed mice.48,49 Moreover, Kim
et al conﬁrmed that cinnamon administration regulated lipid
metabolism via the up-regulation of PPARa expression.19 Sheng
et al reported that PPARa expression increased the cellular uptake
of fatty acids liberated from fat tissues. PPARa ligands also
increased the expression of the lipoprotein lipase gene, resulting in
the anti-hyperlipidemia effect.28 However, some studies did not
ﬁnd any signiﬁcant change in lipids proﬁle after cinnamon con-
sumption or its different extracts.50,51
The strengths of the present study were the double blind
placebo-controlled design with no drop-outs. However, our study
had some limitations including its short study duration of 8 weeks,
small sample population and use of a ﬁxed dose of cinnamon. This
study also included subjects with BMI  25 kg/m2. Therefore, the
results of our studymaynot be applicable to underweight or normal
weight patients with PCOS and also to other doses of cinnamon or
different intervention period. Studies are warranted to evaluate the
effects of cinnamon on androgen status, oxidized LDL and other
indicators of OS in these patients, too.
In conclusion, results of present study indicated that 1.5 g of
cinnamon supplementation for 12 weeks improved antioxidant
status and lipid proﬁle in women with PCOS that could be effective
for this disease.Conﬂict of interest
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